Tag Archives: ATEC

Top Stocks To Buy For 2018

Get to Florida and buy a house. Now.   I'm not kidding. If you wait any longer, you might miss this opportunity. And believe me, you don't want to miss it.   I've personally been buying real estate for years… But the opportunity isn't over. Not even close.   I know what you're thinking…   "Steve, real estate prices have skyrocketed since 2011… Can prices really keep climbing higher?"   The answer is yes. In fact, where I live in northern Florida, houses are downright cheap. And that makes this an opportunity you do not want to miss.   Let me explain…   The median home value in Orlando, Florida is around $161,000, according to Zillow.com. And the median home value in Jacksonville, Florida is $144,000.   I can't tell you that the median home in either of these places is the right home for you, but my point is that Florida real estate is still CHEAP. When I travel the world, I'm stunned by housing prices…

Top Stocks To Buy For 2018: Alphatec Holdings, Inc.(ATEC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Alphatec Holdings Inc (NASDAQ: ATEC) were down around 25 percent to $2.00 as the company reported an $18.9 million private placement.

    Heat Biologics Inc (NASDAQ: HTBX) was down, falling around 15 percent to $0.872. Heat Biologics priced its 5 million share offering at $0.80 per share.

  • [By Lisa Levin] Related Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol-Myers Squibb Partnership; Medgenics Shares Slide 15 Biggest Mid-Day Losers For Monday Cerulean Pharma's (CERU) CEO Chris Guiffre on Cerulean and Dar茅 Proposed Transaction (Transcript) (Seeking Alpha)
    Related Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide Mid-Day Market Update: Dow Rises Over 50 Points; Tandem Diabetes Care Shares Plunge Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket (Seeking Alpha)
    Cerulean Pharma Inc (NASDAQ: CERU) shares dipped 27 percent to $0.817. Cerulean Pharma shares have dropped 60.28 percent over the past 52 weeks, while the S&P 500 index has gained 15.31 percent in the same period.
    Tandem Diabetes Care Inc (NASDAQ: TNDM) shares tumbled 24.2 percent to $1.17. Tandem Diabetes Care priced 18 million share offering at $1.25 per share.
    Alphatec Holdings Inc (NASDAQ: ATEC) shares fell 21.1 percent to $2.10 as the company reported a $18.9 million private placement.
    Heat Biologics Inc (NASDAQ: HTBX) shares dropped 15.5 percent to $0.870. Heat Biologics priced its 5 million share offering at $0.80 per share.
    Rave Restaurant Group Inc (NASDAQ: RAVE) shares fell 15 percent to $1.76.
    QuickLogic Corporation (NASDAQ: QUIK) shares declined 12.2 percent to $1.58. QuickLogic priced its 10 million share offering at $1.50 per share.
    Orion Engineered Carbons SA (NYSE: OEC) shares dropped 9.5 percent to $19.10. Orion Engineered Carbons reported a 5 million common stock secondary offering.
    Interpace Diagnostics Group Inc (NASDAQ: IDXG) shares fell 8.7 percent to $2.61 after the company reported debt restructuring and agreed to eliminate its royalty and mileston

Top Stocks To Buy For 2018: Aaron's, Inc.(AAN)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Best Buy Co now outperforming potential peersactive in electronics retailing such asmid capAaron’s, Inc (NYSE: AAN)and small cap CONN’S, Inc (NASDAQ: CONN):

  • [By Peter Graham]

    Small cap consumer electronics retailer Aaron’s, Inc (NYSE: AAN) reportedQ2 2017 earnings before the market opened on Friday. Revenues were $815.6 million versus $789.4 million. Progressive Leasing’s revenue in the second quarter of 2017 increased 25.1% to $373.5 million, revenue for DAMI was $8.5 million versus$5.3 million and overall revenues for the Aaron’s Business decreased 10.7% to $433.6 million. Same store revenues decreased 8.1% during the second quarter of 2017 and customer count on a same store basis was down 4.8%. Company-operated Aaron’s stores had 932,000 customersas ofJune 30, 2017, a 7.2% decrease from the second quarter of 2016. Net earnings were $36.3 million versus $38.5 million. The CEO commented:

  • [By Peter Graham]

    A long term performance chart shows shares of Best Buy Co outperforming potential peersactive in electronics retailing such asmid capAaron’s, Inc (NYSE: AAN)and small cap CONN’S, Inc (NASDAQ: CONN):

  • [By Peter Graham]

    The Q4 2016 earnings report for small cap consumer electronics retailer Aaron’s, Inc (NYSE: AAN) is scheduled for before the market opens onFriday (February 17). Last time around, shares spiked in the high single digits after better-than-expected third quarterearnings.

  • [By Lisa Levin]

    Friday afternoon, the non-cyclical consumer goods & services sector proved to be a source of strength for the market. Leading the sector was strength from Align Technology, Inc. (NASDAQ: ALGN) and Aaron's, Inc. (NYSE: AAN).

Top Stocks To Buy For 2018: Mammoth Energy Services, Inc. (TUSK)

Advisors’ Opinion:

  • [By Jack Delaney]

    Mammoth Energy Services (Nasdaq: TUSK) provides drilling and related services for North American gas and oil explorers.

    Even though Mammoth was just founded in 2014, it had $243 million in revenue between June 30, 2015, and June 30, 2016.

Top Stocks To Buy For 2018: SemiLEDS Corporation(LEDS)

Advisors’ Opinion:

  • [By Ross Cameron – Warrior Trading]

    I look at stocks like Sunshine Heart Inc (NASDAQ: CHFS), which has a beta of 2.38 (remember, a beta greater than 1 means more volatility), or SemiLEDs Corporation (NASDAQ: LEDS), with a beta of 2.26. Both of these have been recent winners for me. If this means I’m trading penny stocks, then that’s fine. My key is to stick with my system, which is why I’ve been successful — and had the best day of my career).

  • [By Lisa Levin]

    SemiLEDs Corporation (NASDAQ: LEDS) was down, falling around 17 percent to $6.75 following Q2 earnings report. SemiLEDS reported a Q3 loss of $1.06 per share on revenue of $2.4 million.

  • [By Monica Gerson]

    SemiLEDs Corporation (NASDAQ: LEDS) is estimated to post its quarterly earnings.

    Staffing 360 Solutions Inc (NASDAQ: STAF) is expected to post a quarterly loss at $0.28 per share.

Top Stocks To Buy For 2018: Oshkosh Corporation(OSK)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Oshkosh (OSK) was downgraded to neutral from buy at Bank of America/Merrill Lynch. $62 price target. The valuation is less attractive, as the stock is trading at 21x expected 2017 earnings, analysts said. 

  • [By Rich Smith]

      I first named Oshkosh my top stock pick back in September, when the stock cost $42 and change. Since then, the stock has gone down, and sells for $3 less. So am I supposed to dislike Oshkosh stock now?

    No. To the contrary, I like it even more. (About $3 more, in fact).

    You see, even in the process of picking Oshkosh back then, I warned investors: "I don’t know whether Oshkosh will be the best-performing stock in the world in the month of September, but I’ve got a strong hunch about the next six months." And that hunch remains — because the facts have not changed.

    This past summer, Oshkosh was named the winner of the Pentagon’s contract to build a next-gen "Humvee" — an armored Joint Light Tactical Vehicle that will serve the U.S. military for decades to come. Oshkosh won an initial award to produce 17,000 vehicles for $6.7 billion. Ultimately, though, this is a contract that could swell to $30 billion or more for production, maintenance, and upgrade of approximately 55,000 JLTVs across all military branches.

    So why hasn’t Oshkosh stock moved in response to the contract? Mainly because rival bidderLockheed Martin threw a monkey wrench into the contracts process, first protesting the JLTV award to Oshkosh, and then, when that protest was rejected, filing suit in court to try to win the contract away from its rival.

    Personally, I think Lockheed Martin will lose that suit as well. After all, Lockheed’s forte is in fighter jets, while Oshkosh is the military’s premier supplier of trucks like JLTV, as well as the Army’s M-ATV vehicle (a small, all-terrain MRAP). Perhaps recognizing this, AM General, the other company that bid against Oshkosh on JLTV and lost, declined to protest the award. Lockheed took the other road, but I expect it will be a dead end for Lockheed as well.

  • [By Shanthi Rexaline]

    The six companies that met the criterion are:

    Oshkosh Corp (NYSE: OSK). Phillips 66 (NYSE: PSX). SpartanNash Co (NASDAQ: SPTN). Suncor Energy Inc. (USA) (NYSE: SU). Washington Federal Inc. (NASDAQ: WAFD). Barnes & Noble, Inc. (NYSE: BKS).
    Oshkosh

    Oshkosh is a manufacturer of specialty vehicles and vehicle bodies and is based in Wisconsin. The company operates under four business segments, namely access equipment, defense, fire and emergency, and commercial.

stock market performance

If I have to vote for one of the strangest market reactions to a quarterly report, GoPro’s (GPRO) recent Q3’17 numbers are probably on the top of my list.

First of all, GPRO’s management had guided higher two months earlier, stating revenue will be in the upper range between $290M and $310M. Not only did it beat that number (which was already something the market did not expect), but it beat it by a whopping $20M and the revenue increase was 37% Y/Y.

If that was not enough, the company reported GAAP EPS of $0.10 and adjusted EPS of $0.15, blowing the consensus by $0.13.

And the end result was that the stock was down by about 11% on the reporting date. Supposedly, the reason for the drop was guidance that called for about $470M in revenue for Q4 vs. the $520M the market was expecting.

So is the market right or wrong? The market is dead wrong, of course, it just doesn’t know it yet. To give you just one reason why the market is wrong, please take a look at the chart below:

stock market performance: Mallinckrodt plc(MNK)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Mallinckrodt (MNK) tumbled to the bottom of the S&P 500 today after Citron Research accused the company of fraud.

    Getty Images

    Mallinckrodt tumbled 12% to $59.60 today, while the S&P 500 declined 0.2% to 2,176.94.

    Leerink’s Jason Gerberry and Etzer Darout explain the allegations:

    Mallinckrodtshares are down -7-8% based on a short report citing CMS dashboard data which call into question Acthar Gel sales derived from government sources (CMS; Medicaid & Medicare). The report appears to overstate Acthar CMS sales as a percent of total product sales, as the methodology utilized by CMS drug spending dashboard for Medicare spend is based on gross sales, not net., although it’s unclear to what extent Acthar CMS sales are overstated.

    The report suggestsMallinckrodt mgmt understated combined Medicaid/Medicare sales on an investor call, saying it was about a little bit higher than a quarter of the business vs. gross sales on CMS dashboard implying sales were 61% of total Acthar net revenue (an apples to oranges comparison). We dont know the exact net sales of Acthar to Medicare/Medicaid, but we believe it is safe to assume Medicaid, after CPI price penalties had high discounts/rebates and assuming an 80% gross-to-net ratio on the Medicare book ($504m gross) suggests Acthar net sales would be closer to 38-45% range vs. the 61% figure cited in the short-report. Why this may matter Acthar Gel is an old product lacking good randomized, controlled data consistent with most products approved in the modern era. The report appears to be an attempt to call into question whether the government should be paying Acthars average $80-100k net price/patient/year by calling to this to the attention of government figures who have been targeting excessive drug pricing issues. This type of issue became a major headache for Mylan (MYL) investors recently with EpiPen.Mallinckrodt is presenting at a compe

  • [By Keith Speights]

    That’s the question investors are trying to answer about how President Trump’s policies might impact healthcare stocks. So far, specific policy proposals put forward by the president appear likely to cause significant problems for certain healthcare stocks. Here’s why three of President Trump’s policies could be downright terrible for Molina Healthcare(NYSE:MOH), Mallinckrodt (NYSE:MNK), and Illumina (NASDAQ:ILMN).

  • [By Ben Levisohn]

    Mallinckrodt (MNK) tumbled to the bottom of the S&P 500 today after its earnings topped the Street consensus but offered commentary that spooked investors.

    Agence France-Presse/Getty Images

    Shares of Mallinckrodt dropped 9.1% to $52.42, while the S&P 500 rose 0.1%.

    Barclays analyst Douglas Tsao and Morgan Williams callMallinckrodt’s plunge “outsized.” They explain why:

    In our view the sell-off afterMallinckrodt reported CY3Q16 earnings is outsized considering much of the disclosure on the call was largely expected, including specialty generics weakness and the 2017 outlook, which seemed relatively mild. While outsized Acthar contribution to EBITDA may be accounting for some of the sell-off, wed argue that there is benefit to the brand outperforming, especially considering the need to offset Therakos production issues in CY4Q16 and CY1Q17 as well as specialty generics weakness. We recognize some lingering headline risk associated with media reports criticizing the cost of Acthar to Medicare, after CMS released its prescription drug spending dashboard.

    Mallinckrodt’s market capitalization fell to $5.7 billion today from $6.2 billion yesterday. It reported net income of $306 million on revenue of $3.3 billion in 2015.

    This marks the third time in less than two weeks that Mallinckrodt was the S&P 500′s biggest loser.

  • [By Johanna Bennett]

    Sell-side analysts continue to defend drug maker Mallinckrodts (MNK) shares on the heel of Citron Researchs report on the company released last week.

    Earlier today, UBS analyst Marc Goodman and his team weighed into the fray, proclaiming that a misunderstood situation creates opportunity.

    Goodman, who rates Mallinckrodt at a buy with a $92 price target, argues that Mallinckrodt is a different breed from other specialty drug makers, with high-quality earnings, sales growth fueled by volume not price hikes and an emerging pipeline we think is not just underappreciated but really not even part of the conversation with most investors.

    Also, he argues that Mallinckrodt continues to be misunderstood by investors.

    Goodman goes into goes into more detail:

    we were surprised this past week by the debate around Acthar’s Medicare exposure (~30% or ~40%), which in our view has little relevance to the overall MNK story. The key debate since the Questcor deal has been Acthar payer coverage and concerns for more barriers andor coverage blocks by the payers. There was reason for concern just 2 years ago, in our view, as several important payers increased barriers. But mgt’s aggressive focus on enhancing clinical and health-economics data to help support better coverage seems to be working and has resulted in improved coverage, which we believe is still not well appreciated.

    Mallinckrodt shares continue to climb today, rising 4.8% to a recent $57.20.

stock market performance: WashingtonFirst Bankshares Inc(WFBI)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of CASTLE CREEK CAPITAL PARTNERS IV, LP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=CASTLE+CREEK+CAPITAL+PARTNERS+IV%2C+LP

    These are the top 5 holdings of CASTLE CREEK CAPITAL PARTNERS IV, LPGuaranty Bancorp (GBNK) – 1,448,849 shares, 39.1% of the total portfolio. MBT Financial Corp (MBTF) – 1,876,423 shares, 23.6% of the total portfolio. WashingtonFirst Bankshares Inc (WFBI) – 489,377 shares, 15.19% of the total portfolio. Shares added by 4558.07%Eastern Virginia Bankshares Inc (EVBS) – 1,061,225 shares, 12.33% of the total portfolio. First NBC Bank Holding Co (FNBC) – 2,205,382 shares, 9.78% of the total portfolio. Added: Wa

stock market performance: Monotype Imaging Holdings Inc.(TYPE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Monotype Imaging Holdings Inc. (NASDAQ: TYPE) were down around 12 percent to $20.90 after the company posted downbeat quarterly earnings.

  • [By Lisa Levin]

    Wednesday afternoon, the non-cyclical consumer goods & services shares surged 0.61 percent. Meanwhile, top gainers in the sector included Monotype Imaging Holdings Inc. (NASDAQ: TYPE), up 9 percent, and Semiconductor Manufacturing Int'l (ADR) (NYSE: SMI), up 6 percent.

stock market performance: CGG(CGG)

Advisors’ Opinion:

  • [By Jonas Elmerraji]

    First up is French oil service firm CGG Veritas (CGG)
    . The Eurozone-based energy stock hasn’t exactly posted blockbuster performance in 2013, but investors who ignore CGG for the final stretch of the year could be making a big mistake. That’s because of a bullish technical pattern that’s emerging in shares right now.

    CGG spent most of the last eight months looking anything but bullish. But an ascending triangle pattern is changing that. The pattern is formed by horizontal resistance to the upside at $26, and uptrending support to the below shares. Basically, as CGG bounces in between those two technical levels, it’s getting squeezed closer and closer to a breakout above $26. When that happens, traders have a buy signal.

    The ascending triangle pattern in CGG Veritas isn’t exactly textbook. That’s because the setup is forming at the bottom of a downtrend, rather than in the middle of an uptrend – but it’s a mistake to get caught up on the textbook pictures of what trading patterns are supposed to look like. On a move through $26, the trading implications are just as actionable.

  • [By Lisa Levin]

    CGG SA (ADR) (NYSE: CGG) shares shot up 32 percent to $7.15 after the company reported an agreement in principle on financial restructuring plan with main creditors and DNCA.

  • [By Lisa Levin]

    Friday afternoon, the energy sector proved to be a source of strength for the market. Leading the sector was strength from CGG SA (ADR) (NYSE: CGG) and Geospace Technologies Corporation (NASDAQ: GEOS).

stock market performance: Alphatec Holdings, Inc.(ATEC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Alphatec Holdings Inc (NASDAQ: ATEC) were down around 25 percent to $2.00 as the company reported an $18.9 million private placement.

    Heat Biologics Inc (NASDAQ: HTBX) was down, falling around 15 percent to $0.872. Heat Biologics priced its 5 million share offering at $0.80 per share.

  • [By Lisa Levin] Related Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol-Myers Squibb Partnership; Medgenics Shares Slide 15 Biggest Mid-Day Losers For Monday Cerulean Pharma's (CERU) CEO Chris Guiffre on Cerulean and Dar茅 Proposed Transaction (Transcript) (Seeking Alpha)
    Related Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide Mid-Day Market Update: Dow Rises Over 50 Points; Tandem Diabetes Care Shares Plunge Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket (Seeking Alpha)
    Cerulean Pharma Inc (NASDAQ: CERU) shares dipped 27 percent to $0.817. Cerulean Pharma shares have dropped 60.28 percent over the past 52 weeks, while the S&P 500 index has gained 15.31 percent in the same period.
    Tandem Diabetes Care Inc (NASDAQ: TNDM) shares tumbled 24.2 percent to $1.17. Tandem Diabetes Care priced 18 million share offering at $1.25 per share.
    Alphatec Holdings Inc (NASDAQ: ATEC) shares fell 21.1 percent to $2.10 as the company reported a $18.9 million private placement.
    Heat Biologics Inc (NASDAQ: HTBX) shares dropped 15.5 percent to $0.870. Heat Biologics priced its 5 million share offering at $0.80 per share.
    Rave Restaurant Group Inc (NASDAQ: RAVE) shares fell 15 percent to $1.76.
    QuickLogic Corporation (NASDAQ: QUIK) shares declined 12.2 percent to $1.58. QuickLogic priced its 10 million share offering at $1.50 per share.
    Orion Engineered Carbons SA (NYSE: OEC) shares dropped 9.5 percent to $19.10. Orion Engineered Carbons reported a 5 million common stock secondary offering.
    Interpace Diagnostics Group Inc (NASDAQ: IDXG) shares fell 8.7 percent to $2.61 after the company reported debt restructuring and agreed to eliminate its royalty and mileston

share market

OMB Looks Ready to OK Delay of Fiduciary Rule

Trumps New Labor Pick Acosta Likely to Be More Nuanced Than Puzder

How Behavioral Economics Can Help You Retire Rich

The nine plaintiffs suing the Labor Department over its fiduciary rule in a Texas court said late Friday that they are appealing Judge Barbara M.G. Lynn’s Feb. 8 decision upholding Labor’s rule. 

“We remain confident in the merits and strength of our case and stand by our assertion that the Department of Labor exceeded its authority,” said the plaintiffs, which include the U.S. Chamber of Commerce, the Securities Industry and Financial Markets Association, and the Financial Services Institute, in a joint statement announcing the appeal.

You are signed up!

ThinkAdvisor’s TechCenter is an educational resource designed to give you a competitive edge by keeping you abreast of new tech innovations and need-to-know information that can be applied to your business. Resources STRAIGHT-THROUGH PROCESSING FOR THE FINANCIAL SERVICES INDUSTRY

STP can be described as electronically capturing and processing transactions in one pass, from the point of first ‘deal’ to final settlement.

share market: Oaktree Capital Group, LLC(OAK)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Position: Long GLD small, bonds, SDS; short TLT small, SPY small .

  • [By WWW.MONEYSHOW.COM]

    Oaktree Capital Group (OAK) is known for its contrarian approach with many of its products concentrating on distressed assets and turnaround situations.

share market: Amgen Inc.(AMGN)

Advisors’ Opinion:

  • [By Keith Speights]

    Gilead Sciences (NASDAQ:GILD), Bristol-Myers Squibb (NYSE:BMY), and Amgen (NASDAQ:AMGN) stand out as three of the most likely suitors for Incyte. Here’s why these big drugmakers could be interested in making a significant acquisition.

  • [By Ben Levisohn]

    Regeneron Pharmaceuticals (REGN) tumbled to the bottom of the S&P 500 today after a judge said the company could be forced to stop selling an anti-cholesterol drug due to violating an Amgen (AMGN) patent.

  • [By Chris Lange]

    Shares of Amgen Inc. (NASDAQ: AMGN) saw a handy gain to close out the week after the company won a Delaware court ruling that blocked Sanofi (NYSE: SNY) and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) from selling their cholesterol-lowering drug in the United States. Essentially the court found that the drug Praluent actually infringed upon Amgens patents for its rival treatment Repatha.

  • [By Ben Levisohn]

    Three biotech stocks–Alexion Pharmaceuticals (ALXN), Amgen (AMGN), and Celgene (CELG)–reported earnings since yesterday’s close. But just one has seen its shares head higher after the announcement.

share market: Alphatec Holdings, Inc.(ATEC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Alphatec Holdings Inc (NASDAQ: ATEC) were down around 25 percent to $2.00 as the company reported an $18.9 million private placement.

    Heat Biologics Inc (NASDAQ: HTBX) was down, falling around 15 percent to $0.872. Heat Biologics priced its 5 million share offering at $0.80 per share.

  • [By Lisa Levin] Related Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol-Myers Squibb Partnership; Medgenics Shares Slide 15 Biggest Mid-Day Losers For Monday Cerulean Pharma's (CERU) CEO Chris Guiffre on Cerulean and Dar茅 Proposed Transaction (Transcript) (Seeking Alpha)
    Related Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide Mid-Day Market Update: Dow Rises Over 50 Points; Tandem Diabetes Care Shares Plunge Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket (Seeking Alpha)
    Cerulean Pharma Inc (NASDAQ: CERU) shares dipped 27 percent to $0.817. Cerulean Pharma shares have dropped 60.28 percent over the past 52 weeks, while the S&P 500 index has gained 15.31 percent in the same period.
    Tandem Diabetes Care Inc (NASDAQ: TNDM) shares tumbled 24.2 percent to $1.17. Tandem Diabetes Care priced 18 million share offering at $1.25 per share.
    Alphatec Holdings Inc (NASDAQ: ATEC) shares fell 21.1 percent to $2.10 as the company reported a $18.9 million private placement.
    Heat Biologics Inc (NASDAQ: HTBX) shares dropped 15.5 percent to $0.870. Heat Biologics priced its 5 million share offering at $0.80 per share.
    Rave Restaurant Group Inc (NASDAQ: RAVE) shares fell 15 percent to $1.76.
    QuickLogic Corporation (NASDAQ: QUIK) shares declined 12.2 percent to $1.58. QuickLogic priced its 10 million share offering at $1.50 per share.
    Orion Engineered Carbons SA (NYSE: OEC) shares dropped 9.5 percent to $19.10. Orion Engineered Carbons reported a 5 million common stock secondary offering.
    Interpace Diagnostics Group Inc (NASDAQ: IDXG) shares fell 8.7 percent to $2.61 after the company reported debt restructuring and agreed to eliminate its royalty and mileston

share market: PowerShares S&P SmallCap Information Technology Portfolio(PSCT)

Advisors’ Opinion:

  • [By ]

    On this chart, I plotted the year-to-date performance of the Nasdaq Composite index against two exchange-traded funds (ETFs) — one is an ETF that tracks the small-cap Russell 2000 index, and the other is PowerShares S&P SmallCap Information Technology Portfolio ETF (Nasdaq: PSCT), which serves as a proxy for the types of small-cap tech stocks that are a focus of my premium newsletter, Game-Changing Stocks.

  • [By ]

    Overall, our Game-Changing Stocks portfolio has had a good run this year. Our closed positions for 2017 have, on average, returned 28.5% — a much stronger result than what we’ve seen from the Russell 2000 index or from the PowerShares S&P Small Cap Information Technology Portfolio ETF (Nasdaq: PSCT), which returned 13% and 11% year-to-date, respectively. It’s not a fair comparison, of course, because our closed positions all have different time frames, but it does stress the strong promise of game-changing stocks.

share market: Dunkin' Brands Group, Inc.(DNKN)

Advisors’ Opinion:

  • [By WWW.USATODAY.COM]

    While McDonald’s (NYSE: MCD) and Dunkin’ Brands’ (NASDAQ: DNKN) Dunkin’ Donuts both now sell premium espresso-based beverages along with other fancy coffee drinks, people don’t view those brands the way they see Starbucks. The Seattle-based coffee chain exists in its own world, where it can sell out of $10 cups of whisky-barrel-aged coffee while it opens more than a thousand Reserve stores selling pricier drinks than its normal, already expensive beverage lineup.

  • [By Asit Sharma]

    Dunkin’ Brands Group, Inc. (NASDAQ:DNKN) is currently testing a concept in 300 U.S. stores that may surprise many of its investors: a streamlined menu.

  • [By Ben Levisohn]

    Keurigs plight (actually, JABs) is worsening, with the K-cup market slowing to almost no growth now, and Keurig continuing to lose own brands share. Starbucks (SBUX) echoed the notion of a K-cup market slowdown at its seminar on Wednesday (and is guiding for its [consumer packaged goods, or CPG,] growth below recent trends), but it expects to increase its share of total CPG coffee to 20% from 15%. Come early February it will be a year since the closing of the Keurig deal for JAB Holdings. The pressure on JAB is more significant if we take into account the high leverage of the deal (JAB contributed one fourth of the $12Bn price tag). It is a tough predicament. On the one hand we argue that to make that deal work, they need to buy more (own) brands either from the retail channel (that can be extended to CPG: Dunkin (DNKN)? Panera (PNRA)?), or outright buy CPG brands (like the entire Kraft Heinz portfolio, and or Tata Groups Eight OClock brand). But can/how do they fund these deals? Maybe Mars and Warren Buffett (Mars is involved in office coffee with Starbucks), private equity, and or 3G can help? While this note is not about Positive-rated Mondelez, we have mentioned before a scenario where Kraft Heinz buys Mondelez and partly funds the deal by selling its own CPG coffee business (~$3Bn we say) to JAB as well as divests the Mondelez 20% plus stakes in Keurig (North America) and Jacobs Douwe Egberts (Western Europe), which together at this stage are worth ~$7-8Bn. But, yes, JAB will need deep-pocket partners and generous lenders. Net, JAB needs to do something soon.

  • [By John Udovich]

    While theMacys Thanksgiving Day parade sponsored by Macy’s, Inc (NYSE:M) is the most well known corporate sponsoredThanksgiving parade,Dunkin Brands Group Inc (NASDAQ:DNKN) and McDonald’s Corporation (NYSE:MCD) also sponsor parades in major USA cities that will help them grab some extra consumer attention and perhaps help the bottom line a bit.

  • [By Ben Levisohn]

    The market is treating Chipotle as if it is an Amazon, Tesla, Apple or Google, when in fact all they do is make burritos. With the money it would cost you to buy Chipotle today @ $14 billion dollars you could buy Wendy’s (WEN), Cheesecake Factory (CAKE), Papa John’s International (PZZA), and Dunkin’ Brands (DNKN). Chipotle would need to generate at least $24 in earnings per share in order to justify the current market cap — they are not even expected to generate half of that next year. Chipotle is expected to report Q1 on April 25 and the market, in my opinion, has already more than priced in good news.

  • [By Ben Levisohn]

    Dunkin’ Brands Group (DNKN) has dropped 3.5% to $54.16 after getting cut to Sell from Neutral at Goldman Sachs.

    Morgan Stanley (MS) has risen 1.1% to $42.95 after getting upgraded to Buy from Hold at Deutsche Bank.

Top 10 Clean Energy Stocks To Own Right Now

London, X0, based Investment company Origin Asset Management LLP buys Lam Research, Intel, Copart, United Therapeutics, F5 Networks, Reinsurance Group of America, Tenneco, Synnex, Amphenol, Align Technology, sells Aflac, TransDigm Group, Danaher, Sinclair Broadcast Group, Universal Health Services during the 3-months ended 2016-12-31, according to the most recent filings of the investment company, Origin Asset Management LLP. As of 2016-12-31, Origin Asset Management LLP owns 169 stocks with a total value of $1.5 billion. These are the details of the buys and sells.

New Purchases: LRCX, INTC, CPRT, FFIV, APH, LFUS, EVR, VMW, COMM, MGI, Added Positions: UTHR, RGA, TEN, SNX, ALGN, BERY, JPM, SNPS, ORBK, PRAH, Reduced Positions: TDG, DHR, NTES, SBGI, UHS, TRV, PRXL, MLNX, TSM, CMCSA, Sold Out: AFL, SAFM, IFF, ICE, NOAH, CHT, BMY, DIS, FTV, NLS,

For the details of Origin Asset Management LLP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Origin+Asset+Management+LLP

Top 10 Clean Energy Stocks To Own Right Now: American Capital, Ltd.(ACAS)

Advisors’ Opinion:

  • [By Monica Gerson]

    American Capital Ltd. (NASDAQ: ACAS) shares rose 5.63 percent to $16.50 in the pre-market trading session as Ares Capital Corporation (NASDAQ: ARCC) reported the purchase of American Capital at $3.4 billion in cash and stock.

Top 10 Clean Energy Stocks To Own Right Now: Alphatec Holdings, Inc.(ATEC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Alphatec Holdings Inc (NASDAQ: ATEC) were down around 25 percent to $2.00 as the company reported an $18.9 million private placement.

    Heat Biologics Inc (NASDAQ: HTBX) was down, falling around 15 percent to $0.872. Heat Biologics priced its 5 million share offering at $0.80 per share.

  • [By Lisa Levin] Related Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol-Myers Squibb Partnership; Medgenics Shares Slide 15 Biggest Mid-Day Losers For Monday Cerulean Pharma's (CERU) CEO Chris Guiffre on Cerulean and Dar茅 Proposed Transaction (Transcript) (Seeking Alpha)
    Related Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide Mid-Day Market Update: Dow Rises Over 50 Points; Tandem Diabetes Care Shares Plunge Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket (Seeking Alpha)
    Cerulean Pharma Inc (NASDAQ: CERU) shares dipped 27 percent to $0.817. Cerulean Pharma shares have dropped 60.28 percent over the past 52 weeks, while the S&P 500 index has gained 15.31 percent in the same period.
    Tandem Diabetes Care Inc (NASDAQ: TNDM) shares tumbled 24.2 percent to $1.17. Tandem Diabetes Care priced 18 million share offering at $1.25 per share.
    Alphatec Holdings Inc (NASDAQ: ATEC) shares fell 21.1 percent to $2.10 as the company reported a $18.9 million private placement.
    Heat Biologics Inc (NASDAQ: HTBX) shares dropped 15.5 percent to $0.870. Heat Biologics priced its 5 million share offering at $0.80 per share.
    Rave Restaurant Group Inc (NASDAQ: RAVE) shares fell 15 percent to $1.76.
    QuickLogic Corporation (NASDAQ: QUIK) shares declined 12.2 percent to $1.58. QuickLogic priced its 10 million share offering at $1.50 per share.
    Orion Engineered Carbons SA (NYSE: OEC) shares dropped 9.5 percent to $19.10. Orion Engineered Carbons reported a 5 million common stock secondary offering.
    Interpace Diagnostics Group Inc (NASDAQ: IDXG) shares fell 8.7 percent to $2.61 after the company reported debt restructuring and agreed to eliminate its royalty and mileston

Top 10 Clean Energy Stocks To Own Right Now: SolarWindow Technologies, Inc. (WNDW)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    SolarWindow Technologies, Inc. (OTCQB:WNDW) is another third-party currently engaged in research and development to incorporate one of GLW’s glass products in an innovative manner. WNDW, a leading developer of transparent electricity-generating coatings for glass windows and flexible veneers, announced its plan to develop electricity-generating flexible glass. In particular, WNDW’s scientists and engineers recently applied layers of its liquid coatings onto GLW’s Willow Glass and laminated them under conditions that simulate the high pressure and temperatures of the manufacturing processes used by commercial glass and window producers. The result was a bendable glass “veneer” which generates electricity. WNDW anticipates installing these sheets of electricity-generating glass veneers over existing office tower windows, turning buildings into vertical power generators and helping decrease their carbon footprint. The company also believes that such veneers could be applied to flat and curved surfaces on automobiles, trucks, buses, airplanes, and boats to generate onboard electrical power. WNDW’s veneer products are being developed in collaboration with the U.S. Department of Energy’s National Renewable Energy Laboratory in an effort to commercialize WNDW’s products. While we saw no specific timeline for when WNDW would offer its products incorporating Willow Glass, we are once again excited by this innovative use of a GLW product.

Top 10 Clean Energy Stocks To Own Right Now: Sandstorm Gold Ltd(SAND )

Advisors’ Opinion:

  • [By Rich Duprey]

    Sandstorm Gold (NYSEMKT:SAND) has outperformed the precious metal itself over the past year, with shares rising 35% year to date. Last month it reported third-quarter profits of $7 million, a big U-turn from 2015, when it suffered losses of $5.5 million. In fact, its entire operation was doing better with greater production: lower cash costs, but higher cash margins; and greater operating cash flows, all of which allowed it to pay down its revolving credit facility. That means it has no bank debt and its entire $110 million revolving credit facility is available to make acquisitions.

Top 10 Clean Energy Stocks To Own Right Now: Fogo de Chao, Inc.(FOGO)

Advisors’ Opinion:

  • [By Monica Gerson]

    Fogo De Chao Inc (NASDAQ: FOGO) is expected to post its quarterly earnings at $0.28 per share on revenue of $76.80 million.

    Constellium NV (NYSE: CSTM) is estimated to report its quarterly earnings at $0.06 per share on revenue of $1.18 billion.

Top 10 Clean Energy Stocks To Own Right Now: Intec Pharma Ltd.(NTEC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Intec Pharma Ltd (NASDAQ: NTEC) shares dropped 25 percent to $5.57. Intec Pharma reported a Q3 loss of $0.29 per share.

    Shares of Diplomat Pharmacy Inc (NYSE: DPLO) were down 23 percent to $14.71. Diplomat Pharmacy agreed to buy LDI Integrated Pharmacy Services. Baird downgraded Diplomat Pharmacy from Outperform to Neutral.

  • [By Lisa Levin]

    Intec Pharma Ltd (NASDAQ: NTEC) shares were also up, gaining 14 percent to $5.53. Intec Pharma priced 10.6 million share offering at $4.70 per share.

Top 10 Clean Energy Stocks To Own Right Now: Raytheon Company(RTN)

Advisors’ Opinion:

  • [By Rich Smith]

    On one particularly big news day, April 28, the DSCA announced that it has notified Congress of no fewer than seven separate pending arms sales that it plans to push through. These deals are aiming to sell:

    110 radar-seeking air-to-ground “HARM” missiles to Australia, generating sales of $137.6 million for prime contractors Orbital ATK (NYSE:OA) and Raytheon (NYSE:RTN). Four P-8A Poseidonsubmarine-hunting jet aircraft to New Zealand — a $1.46 billion payday for Boeing (NYSE:BA). 13 76 mm cannonfor installation aboard Israeli Navy SA’AR 4.5 and SA’AR 6 Missile Patrol Boats at a purchase price of $440 million. (Italian firm Leonardo S.p.a.’s DRS North America subsidiary will be the contractor on that one.) Nine Bell 429light utility helicopters to Slovakia, yielding sales of $150 million for Textron (NYSE:TXT). And five CH-47D Chinookhelicopters, sold out of U.S. government surplus to Greece for $80 million.

    Also included in the DSCA’s list of pending contracts are two directed toward the NATO Support and Procurement Agency, specifically:

  • [By Money Morning News Team]

    If you’re looking for one of thebest investments today, it’s hard to beat Raytheon Co. (NYSE: RTN). It doesn’t matter if the market is up or down, defense spending continues to increase. In the past year, global annual defense spending hit $1.6 trillion, and this is considered to be an industry that is likely to continue to grow for the foreseeable future.

  • [By Money Morning News Team]

    Our No. 2 pick, Raytheon Co. (NYSE: RTN), is involved in engineering technology for defense systems, government electronics, and information technology. Its largest and most profitable segments are Integrated Defense Systems (IDS) and Missile Systems (MS).

Top 10 Clean Energy Stocks To Own Right Now: The Middleby Corporation(MIDD)

Advisors’ Opinion:

  • [By Monica Gerson]

    Middleby Corp (NASDAQ: MIDD) is expected to post its quarterly earnings at $0.84 per share on revenue of $515.56 million.

    Jack in the Box Inc. (NASDAQ: JACK) is estimated to post its quarterly earnings at $0.70 per share on revenue of $360.22 million.

Top 10 Clean Energy Stocks To Own Right Now: Cherry Hill Mortgage Investment Corporation(CHMI)

Advisors’ Opinion:

  • [By Lisa Levin] Related Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol-Myers Squibb Partnership; Medgenics Shares Slide 15 Biggest Mid-Day Losers For Monday Cerulean Pharma's (CERU) CEO Chris Guiffre on Cerulean and Dar茅 Proposed Transaction (Transcript) (Seeking Alpha)
    Related Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide Mid-Day Market Update: Dow Rises Over 50 Points; Tandem Diabetes Care Shares Plunge Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket (Seeking Alpha)
    Cerulean Pharma Inc (NASDAQ: CERU) shares dipped 27 percent to $0.817. Cerulean Pharma shares have dropped 60.28 percent over the past 52 weeks, while the S&P 500 index has gained 15.31 percent in the same period.
    Tandem Diabetes Care Inc (NASDAQ: TNDM) shares tumbled 24.2 percent to $1.17. Tandem Diabetes Care priced 18 million share offering at $1.25 per share.
    Alphatec Holdings Inc (NASDAQ: ATEC) shares fell 21.1 percent to $2.10 as the company reported a $18.9 million private placement.
    Heat Biologics Inc (NASDAQ: HTBX) shares dropped 15.5 percent to $0.870. Heat Biologics priced its 5 million share offering at $0.80 per share.
    Rave Restaurant Group Inc (NASDAQ: RAVE) shares fell 15 percent to $1.76.
    QuickLogic Corporation (NASDAQ: QUIK) shares declined 12.2 percent to $1.58. QuickLogic priced its 10 million share offering at $1.50 per share.
    Orion Engineered Carbons SA (NYSE: OEC) shares dropped 9.5 percent to $19.10. Orion Engineered Carbons reported a 5 million common stock secondary offering.
    Interpace Diagnostics Group Inc (NASDAQ: IDXG) shares fell 8.7 percent to $2.61 after the company reported debt restructuring and agreed to eliminate its royalty and mileston

Top 10 Clean Energy Stocks To Own Right Now: Credicorp Ltd.(BAP)

Advisors’ Opinion:

  • [By Zacks]

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
     
    Bank of Nova Scotia (The) (NYSE: BNS): Free Stock Analysis Report
     
    Banco Bilbao Viscaya Argentaria S.A. (NYSE: BBVA): Free Stock Analysis Report
     
    Credicorp Ltd. (NYSE: BAP): Free Stock Analysis Report
     
    Bank of N.T. Butterfield & Son Limited (The) (NTB): Free Stock Analysis Report
     
    To read this article on Zacks.com click here.

Top Clean Energy Stocks To Watch For 2018

Back in September, Vitality Biopharma Inc (OTCMKTS:VBIO) CEO Robert Brooke officially announced his company would be entering the painkiller market, specifically taking aim at the development of an alternative to opioids. His specific words? “Opiates are one of the key classes of drugs we’re seeking to replace, or to make far less necessary, as our proprietary cannabosides could provide a potent alternative form of pain relief and help avoid, or greatly reduce, the use of opiates for the treatment of many conditions…”

The need is tremendous. Brooke’s letter/announcement went on to explain that roughly 80% of heroin users developed a drug habit starting with prescription opioid pain killers.

The timing was uncanny, for VBIO shareholders. A few days following the release of Brooke’s decision to take the company in new direction, Fox News published a story entitled “Medical marijuana programs may help cut opioid use.” It widely confirmed — and legitimized — the bulk of everything Brooke knows, and said. Namely, the Fox News story offered some encouraging data on the potential of medical marijuana…cannabis as an alternative painkiller in particular. Specifically, the commentary cited data from a recent submission to the American Journal of Public Health, which explained “The researchers found that the rates of opioid use decreased in adults ages 21 to 40 in states that had legalized medical marijuana and where residents with prescriptions could obtain cannabis from dispensaries or grow their own, compared to states that had legalized medical marijuana but did not yet have an operational program for people to obtain it.”

Top Clean Energy Stocks To Watch For 2018: Oriental Financial Group Inc.(OFG)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap OFG Bancorp (NYSE: OFG) is a diversified financial holding company that operates under U.S. and Puerto Rico banking laws and regulations. Its three principal subsidiaries, Oriental Bank, Oriental Financial Services and Oriental Insurance, provide a full range of commercial, consumer and mortgage banking services, as well as financial planning, trust, insurance, investment brokerage and investment banking services, primarily in Puerto Rico, through 48 financial centers.

Top Clean Energy Stocks To Watch For 2018: MakeMyTrip Limited(MMYT)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, technology shares fell 0.69 percent. Meanwhile, top losers in the sector included MakeMyTrip Limited (NASDAQ: MMYT), down 8 percent, and Western Digital Corp (NASDAQ: WDC) down 5 percent.

Top Clean Energy Stocks To Watch For 2018: Guidewire Software, Inc.(GWRE)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Ebix Inc actually performing well since the end of 2014 while mid cap peer Guidewire Software Inc (NYSE: GWRE) has been outperforming over a longer period of time and small cap Benefitfocus Inc (NASDAQ: BNFT) has underperformed:

  • [By Monica Gerson]

    Guidewire Software Inc (NYSE: GWRE) is estimated to post its quarterly earnings at $0.06 per share on revenue of $92.43 million.

    Analogic Corporation (NASDAQ: ALOG) is projected to post its quarterly earnings at $0.88 per share on revenue of $127.30 million.

Top Clean Energy Stocks To Watch For 2018: Concord Medical Services Holdings Limited(CCM)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Wednesday,our Under the Radar Moversnewsletter suggested going long on small cap China basedhealthcare equipment and management services stock Concord Medical Services Holdings Ltd (NYSE: CCM):

Top Clean Energy Stocks To Watch For 2018: Alphatec Holdings, Inc.(ATEC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Alphatec Holdings Inc (NASDAQ: ATEC) were down around 25 percent to $2.00 as the company reported an $18.9 million private placement.

    Heat Biologics Inc (NASDAQ: HTBX) was down, falling around 15 percent to $0.872. Heat Biologics priced its 5 million share offering at $0.80 per share.

  • [By Lisa Levin] Related Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol-Myers Squibb Partnership; Medgenics Shares Slide 15 Biggest Mid-Day Losers For Monday Cerulean Pharma's (CERU) CEO Chris Guiffre on Cerulean and Dar茅 Proposed Transaction (Transcript) (Seeking Alpha)
    Related Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide Mid-Day Market Update: Dow Rises Over 50 Points; Tandem Diabetes Care Shares Plunge Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket (Seeking Alpha)
    Cerulean Pharma Inc (NASDAQ: CERU) shares dipped 27 percent to $0.817. Cerulean Pharma shares have dropped 60.28 percent over the past 52 weeks, while the S&P 500 index has gained 15.31 percent in the same period.
    Tandem Diabetes Care Inc (NASDAQ: TNDM) shares tumbled 24.2 percent to $1.17. Tandem Diabetes Care priced 18 million share offering at $1.25 per share.
    Alphatec Holdings Inc (NASDAQ: ATEC) shares fell 21.1 percent to $2.10 as the company reported a $18.9 million private placement.
    Heat Biologics Inc (NASDAQ: HTBX) shares dropped 15.5 percent to $0.870. Heat Biologics priced its 5 million share offering at $0.80 per share.
    Rave Restaurant Group Inc (NASDAQ: RAVE) shares fell 15 percent to $1.76.
    QuickLogic Corporation (NASDAQ: QUIK) shares declined 12.2 percent to $1.58. QuickLogic priced its 10 million share offering at $1.50 per share.
    Orion Engineered Carbons SA (NYSE: OEC) shares dropped 9.5 percent to $19.10. Orion Engineered Carbons reported a 5 million common stock secondary offering.
    Interpace Diagnostics Group Inc (NASDAQ: IDXG) shares fell 8.7 percent to $2.61 after the company reported debt restructuring and agreed to eliminate its royalty and mileston

Top Clean Energy Stocks To Watch For 2018: Xerium Technologies Inc.(XRM)

Advisors’ Opinion:

  • [By kiplinger]

     52-week high: $18.93 


    52-week low: $11.01 

    Annual revenues: $492.9 million 

    Xerium Technologies (XRM), a manufacturer of products used in papermaking, is a favorite of micro-cap expert Dan Abramowitz, who heads Hillson Financial Management, in Rockville, Md. Abramowitz calls the company “a turnaround story that is now at an inflection point.” Changes that a new management team put into effect in 2012 should start bearing fruit. The stock’s price-earnings ratio is a mere 7, based on the average of analysts’ earnings estimates for 2016.